Field trials of a vaccine against bovine mastitis. 1. Evaluation in heifers

Journal of Dairy Science
Jose GiraudoR Nagel

Abstract

A vaccine was developed against bovine mastitis based on inactivated, highly encapsulated Staphylococcus aureus cells; a crude extract of Staph. aureus exopolysaccharides; and inactivated, unencapsulated Staph, aureus and Streptococcus spp. cells. This vaccine was tested on 30 heifers during a 7-mo period. The 30 heifers were randomly assigned to three groups of 10 heifers each. The prepartum group received two injections of the vaccine at 8 and 4 wk before calving, and the postpartum group received two injections at 1 and 5 wk after calving. The control group received two injections of a placebo at 8 and 4 wk before calving. The vaccine or the placebo was administered subcutaneously in the brachiocephalicus muscle of the neck. The frequencies of intramammary infections caused by Staph. aureus were reduced from 18.8% for heifers in the control group to 6.7 and 6.0% for heifers in the prepartum and postpartum groups, respectively. This protective effect was maintained for at least 6 mo. The relative risk of mastitis caused by Staph. aureus was 0.31 and 0.28 for heifers in the prepartum and postpartum groups, respectively, compared with that for heifers in the control group. The results of the trial indicated the effectiveness of...Continue Reading

References

Sep 1, 1979·Somatic Cell Genetics·M M Gottesman
Oct 1, 1991·Journal of Dairy Science·A J GuidryL M Berning
Feb 1, 1989·Journal of Dairy Science·L K Fox, D D Hancock
Jan 1, 1988·Veterinary Microbiology·J L Watts
May 1, 1971·Australian Veterinary Journal·E O Brookbanks
Mar 20, 1971·The Veterinary Record·G RedaelliL Guallini
Dec 1, 1968·Australian Veterinary Journal·E Munch-Petersen
Apr 1, 1984·Diagnostic Microbiology and Infectious Disease·R D ArbeitJ B Robbins
Aug 1, 1983·Veterinary Microbiology·N L Norcross, J P Opdebeeck
Mar 1, 1984·Journal of Dairy Science·K YoshidaW B Evans
Nov 1, 1993·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·H RamponeA Calzolari
Mar 1, 1958·Journal of Bacteriology·R A FINKELSTEIN, S E SULKIN

❮ Previous
Next ❯

Citations

Dec 4, 2012·The Journal of Dairy Research·Ignacio D FrolaCristina I Bogni
Oct 1, 2009·Genetics and Molecular Biology·Isabela FonsecaSimone E F Guimarães
Jul 27, 2001·Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health·M HoedemakerE Bleckmann
Feb 19, 2002·Journal of Veterinary Medicine. A, Physiology, Pathology, Clinical Medicine·B A TenhagenW Heuwieser
Mar 26, 1998·FEMS Immunology and Medical Microbiology·M I GómezD O Sordelli
Dec 2, 2020·Animals : an Open Access Journal From MDPI·Maros CobirkaPetr Slama
Oct 1, 2003·Veterinary Microbiology·Karin Jacobsson

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.